Irit Arbel, PhD
Dr. Irit Arbel, one of BrainStorm’s co-founders, joined the Company in May 2004 as a Director and served as President of the company for six months. Dr. Arbel brings significant senior multidisciplinary biopharma experience to BrainStorm’s board. Currently, Dr. Arbel is the Chair of the Governance, Nominating and Compensation Committee. Dr. Arbel has served as Executive Vice President of Research and Development at Savicell Diagnostic, a biotechnology company, since July 2012. From 2009 through 2011, Dr. Arbel served as Chairperson of Real Aesthetics, a company specializing in cellulite
ultrasound treatment, and BRH Medical, a developer of medical devices for wound healing.
She was also Director of M&A at RFB Investment House, a private investment firm focusing on early stage technology-related companies. Previously, Dr. Arbel was President and Chief Executive Officer of Pluristem Life Systems, a biotechnology company, and prior to that, Israeli Sales Manager of Merck, Sharp & Dohme, a pharmaceutical company.
Dr. Arbel earned her PhD in 1997 in Neurobiology, after performing research in the area of MS. Dr. Arbel also holds a Chemical Engineering degree from the Technion, Israel’s Institute of Technology.